Article
16 Sep 2025
FDA Makes Good On Promise To Publish CRLs For Unapproved Drugs And Biologics
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
28 Jan 2025
2024 FDA Enforcement Review: Quality And Transparency Remain Critical Concerns
Article
09 Jan 2025
Clinical Trial Protocol Deviations: A New FDA Draft Guidance To Ring In The New Year
Article
11 Dec 2024
Stem Cell Litigation Update: FDA Won The Latest Battle, But The Future Of HCT/P Enforcement Remains Unclear
Article
20 Nov 2024
Controlling Opinions: Navigating DEA Diversion Investigations (Podcast)
Article
08 Nov 2024
Hospital And Health Systems Reimbursement Check - November 2024
Article
24 Oct 2024
Non-binding Guidance: The Demise Of Chevron And Implications For Future APA Challenges (Podcast)
Article
03 Jul 2024
Non-Binding Guidance: FDA Regulatory & Enforcement Risks Relevant To Academic Medical Centers, Health Systems And Research Institutions (Podcast)
Article
11 Jun 2024
Medical Device Enforcement Update: Two Recent Settlements Pack A Punch
Article
08 Mar 2024
What's Next For Drug Importation? Potential Next Steps After FDA Authorizes Florida's Section 804 Importation Program
Article
23 Jan 2024
U.S. Life Sciences Regulatory And Compliance Outlook 2024 (Part I): FDA Enforcement And Litigation (Podcast)
Article
02 Jan 2024
First Circuit Affirms Convictions Of Former Acclarent Executives Related To Off-Label Promotion Of Medical Device
Article
23 Nov 2023
Controlling Opinions: Introducing Ropes & Gray's Controlled Substances Compliance Update (Podcast)
Article
07 Nov 2023
Lessons From The Pandemic: FDA Proposes Permanently Adopting Alternative Tools For Drug Facility Inspections
Article
01 Nov 2023
Non-binding Guidance: FDA's Proposed Rule On Laboratory Developed Tests (Podcast)
Article
27 Jul 2023
Women @ RopesTalk: Conversation With Jennifer Zachary, Merck (Podcast)
Article
10 Mar 2022
FDA Proposed Rule Would Harmonize U.S. Quality System Requirements For Medical Devices With International Standard
Article
17 Feb 2022
2021 Enforcement Review: FDA-Regulated Medical Products
Article
03 Feb 2022
DOJ Increases Focus On Clinical Trial Fraud
Article
17 Jan 2022
Contemplating A Post-COVID Return To "Normal Operations": FDA's Transition Plans For Devices Marketed Under Emergency Use Authorizations And Enforcement Policies